Yahoo
LSE - Delayed Quote GBp

Physiomics Plc (PYC.L)

0.4250 0.0000 (0.00%)
At close: October 30 at 4:20:15 PM GMT
Chart Range Bar
Loading chart for PYC.L
  • Previous Close 0.4250
  • Open 0.4375
  • Bid 0.4000 x --
  • Ask 0.4500 x --
  • Day's Range 0.4110 - 0.4375
  • 52 Week Range 0.2530 - 0.8000
  • Volume 3,261,089
  • Avg. Volume 3,198,488
  • Market Cap (intraday) 1.926M
  • Beta (5Y Monthly) 1.03
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Physiomics Plc engages in the provision of consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.

www.physiomics.co.uk

11

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

PYC.L
49.12%
FTSE 100 (^FTSE)
8.04%

1-Year Return

PYC.L
0.00%
FTSE 100 (^FTSE)
9.94%

3-Year Return

PYC.L
68.52%
FTSE 100 (^FTSE)
46.43%

5-Year Return

PYC.L
93.20%
FTSE 100 (^FTSE)
48.25%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -66.06%

  • Return on Assets (ttm)

    -50.98%

  • Return on Equity (ttm)

    -114.63%

  • Revenue (ttm)

    1.06M

  • Net Income Avi to Common (ttm)

    -697.03k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    418.63k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -281.94k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: